No Matches Found
No Matches Found
No Matches Found
908 Devices, Inc. Hits New 52-Week High of $9.00
908 Devices, Inc. has achieved a new 52-week high of USD 9.00, significantly up from its low of USD 1.81, reflecting a strong performance with a 44.77% gain over the past year. The company, with a market cap of USD 204 million, remains loss-making but resilient in the competitive pharmaceuticals sector.
908 Devices, Inc. Hits New 52-Week High at $8.79
908 Devices, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has achieved a new 52-week high of USD 8.79, reflecting a 41.06% increase from its low of USD 1.81. With a market cap of USD 204 million, the company shows resilience despite being loss-making.
908 Devices, Inc. Hits New 52-Week High of $8.29
908 Devices, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, recently achieved a new 52-week high of USD 8.29, reflecting a significant performance increase over the past year. With a market capitalization of USD 204 million, the company continues to navigate challenges while maintaining resilience in a competitive industry.
Is 908 Devices, Inc. technically bullish or bearish?
As of July 29, 2025, 908 Devices, Inc. shows a mildly bullish trend with strong year-to-date performance of 210%, despite some caution from weekly indicators.
What does 908 Devices, Inc. do?
908 Devices, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $12 million and a net loss of $10 million as of March 2025, with a market cap of $263.58 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -16.05%.
How big is 908 Devices, Inc.?
As of Jun 18, 908 Devices, Inc. has a market capitalization of 263.58 million, with net sales of 61.42 million and a net profit of -71.14 million over the latest four quarters. Shareholder's funds are 114.59 million, and total assets are valued at 159.48 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
